About
In this session, three leaders from Reinsurance Group of America, Incorporated (RGA) share their views from different, yet integrated, perspectives to help insurers make sense of the evolving global pandemic.

Dr. Daniel Zimmerman guides us through a general medical and epidemiological overview of COVID-19 and what we’ve learned in the last five months. His insights highlight the key factors that will affect the pandemic’s trajectory and are critical for insurers to understand.

Julianne Callaway shares research insights uncovered from RGA’s wide-ranging expertise combining the scientific, advanced analytics, and actuarial knowledge of RGA’s Global Research and Data Analytics team. She discusses findings regarding three key components that impact COVID-19 mortality experience: age, underlying chronic health conditions, and gender. Additionally, she explores ways insurers can cope with the challenges of studying an evolving issue with often incomplete data.

While much of the focus has been on the immediate impact of COVID-19 on the industry, Tim Rozar has an eye on the future. He shares his views on the near-term and lasting impacts of this pandemic on the insurance industry and society, including the potential for additional challenges as well as an improved outlook.
When
Tue, May 12, 2020 · 2:00 PM Eastern Time (US & Canada) (GMT -4:00)
Presenters
1588193900-982981d32a7a4dd1
Julianne Callaway FSA, ACAS, MAAA
Vice President and Actuary, Strategic Research, RGA
As Vice President and Actuary, Strategic Research for RGA’s Global Research and Data Analytics (GRDA) team, Julianne Callaway researches emerging areas of interest to the insurance industry. Her insights on wellness, wearable technology, genetics and areas of strategic research informs innovative business strategy and is shared with clients in presentations, white papers and articles.
Julianne joined RGA in 2013 as an Assistant Actuary in GRDA, where she oversaw research development for the department. Later Julianne was the research lead for RGAX, the wholly-owned innovation incubator subsidiary of Reinsurance Group of America, Incorporated, for two years where she developed economic models for business concepts and market intelligence in support of innovative business initiatives.
Julianne has Bachelor of Science (B.S.) and Master of Arts (M.A.) degrees, both in economics, from the University of Missouri – Columbia. She is a Fellow in the Society of Actuaries (FSA), an Associate in the Casualty Actuarial Society (ACAS), and Member of the American Academy of Actuaries (MAAA). A prolific author, she has written and published several articles and white papers on a broad range of insurance topics. She is also a frequent speaker at industry conferences, and is currently a member of the Society of Actuaries’ General Insurance Research Committee.
1588194028-699c46e379fc7011
Daniel D. Zimmerman M.D.
Senior Vice President and Chief Medical Director, Global Support Team, RGA
Daniel D. Zimmerman, M.D., is Senior Vice President and Chief Medical Director of RGA and a member of RGA’s Global Support Team. He is responsible for thought leadership, case consultation, product development, and internal and external education. Additionally, he serves as editor of ReFlections, RGA’s global medical newsletter.
He is also Managing Director of the Longer Life Foundation (LLF), www.longerlife.org, the not-for-profit collaboration between RGA and Washington University School of Medicine in St. Louis that funds clinical research into lifestyle, environmental, and genetic factors that impact mortality and morbidity.
Before joining RGA in 2014, Dr. Zimmerman was a medical director with Northwestern Mutual Life Insurance Company for eight years. Previously, he practiced primary care internal medicine and pediatrics in Tampa, Florida.
Dr. Zimmerman received his medical degree from the University of Wisconsin School of Medicine and Public Health and his undergraduate degree in Medical Microbiology and Molecular Biology from the University of Wisconsin – Madison. He has held leadership positions with the American Council of Life Insurers (ACLI), participated in program committees of the American Academy of Insurance Medicine (AAIM), and frequently represents RGA to key industry professional organizations. He has also contributed several articles to the Journal of Insurance Medicine, On The Risk, and Best’s Review.
1588194606-9351044c3c3fe4a4
Timothy L. Rozar FSA, CERA, MAAA
Senior Vice President, Chief of Staff to the CEO, RGA
As Chief of Staff for RGA, Timothy L. Rozar performs a multifaceted role that includes leading multiple corporate initiatives, both domestically and internationally, in support of the executive office.
Prior to his current role, Tim served as CEO of RGAx, the innovation accelerator of RGA. Tim started his career with RGA in 1996 as a pricing actuary and has previously led RGA’s U.S. product development, management information and research teams. Tim also served as RGA’s Global Head of Research and Data Analytics, overseeing predictive analytics, biometric research, competitive intelligence and actuarial experience analysis.
Tim is a Fellow of the Society of Actuaries (FSA), a Chartered Enterprise Risk Analyst (CERA), and a Member of the American Academy of Actuaries (MAAA). He has served on the Board of Directors of the Society of Actuaries and as chair of the Society of Actuaries’ Product Development Section Council. He received his Bachelor of Science (B.S.) degree in actuarial science from Maryville University, and his M.B.A. from the Olin Business School at Washington University in St. Louis.